The results showed that high expression of CXCL12 had a strong trend to be associated with resistance to anti-PD-1 therapy, and patients with high CXCL12 expression presented with adverse survival after anti-PD-1 therapy (Fig. 6 g-i).
← all excerpts
The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p.
1
—
—